Lamictal and Weight increased - a phase IV clinical study of FDA data
Summary:
Weight increased is reported as a side effect among people who take Lamictal (lamotrigine), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Seroquel, and have Depression.
The phase IV clinical study analyzes which people have Weight increased when taking Lamictal. It is created by eHealthMe based on reports of 74,218 people who have side effects when taking Lamictal from the FDA, and is updated regularly.
What is Lamictal?
Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 82,623 Lamictal users. Check the latest studies of Lamictal.
What is Weight increased?
Weight increased is found to be associated with 2,896 drugs and 3,939 conditions by eHealthMe. Check the latest studies of Weight increased.
74,218 people reported to have side effects when taking Lamictal.
Among them, 1,993 people (2.69%) have Weight increased.

Among these 1,993 people:
How long have people been on Lamictal when they have Weight increased? *
What is the gender of people who have Weight increased when taking Lamictal? *
What is the age of people who have Weight increased when taking Lamictal? *
What are other drugs people take besides Lamictal? *
What are other side effects people have besides Weight increased? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lamictal and have Weight increased?
- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lamictal:
- Lamictal (82,623 reports)
Weight increased treatments and more:
- Weight increased (279,365 reports)
How severe was Weight increased and when was it recovered:
Expand to all the drugs that have ingredients of lamotrigine:
- Weight increased and drugs with ingredients of lamotrigine (3,235 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lamictal:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Weight increased:
- Weight increased (2,896 drugs)
Browse all the conditions that are associated with Weight increased:
- Weight increased (3,939 conditions)
Related publications that referenced our studies
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lamotrigine (the active ingredients of Lamictal) and Lamictal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Peppermint and Ibuprofen - 14 seconds ago
- Drug interactions of Azor and Q10 - 24 seconds ago
- Could Cidofovir cause Multiple-Drug Resistance? - 31 seconds ago
- Could Ciclosporin cause Pneumothorax? - 33 seconds ago
- Could Lexapro cause Osteitis? - 42 seconds ago
- Drug interactions of Cannabis and Ceftriaxone - 51 seconds ago
- Could Ibu cause Cardiac Aneurysm? - 54 seconds ago
- Drug interactions of Phenergan and Glutamine - 58 seconds ago
- Could Lexapro cause Antidepressant Drug Level Increased? - a minute ago
- Drug interactions of Lipitor and Cozaar - a minute ago